A multinational, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda.
Weill Cornell Medicine physician-scientists Dr. Niroshana Anandasabapathy and Dr. Rohit Chandwani have been elected members of the American Society for Clinical Investigation for 2025.
Weill Cornell Medicine and the Cornell Jeb E. Brooks School of Public Policy have established the Cornell Health Policy Center to serve as the locus for health policy impact, research and training across Cornell.
A person’s “bioenergetic age” – or how youthfully their cells generate energy – might be a key indicator of whether they’re at risk of developing Alzheimer’s disease, new research from Weill Cornell Medicine shows.
Bacteria naturally present in the human intestine can transform cholesterol-derived bile acids into powerful metabolites that strengthen anticancer immunity by blocking androgen signaling, according to a preclinical study.
Smolka, a biochemist and former interim director of the Weill Institute for Cell and Molecular Biology, will support life sciences across the university.
Researchers at Weill Cornell Medicine developed a more effective model for predicting how patients with muscle-invasive bladder cancer will respond to chemotherapy.